25 XP   0   0   10

Revolution Medicines Inc
Buy, Hold or Sell?

Let's analyse Revolution Medicines Inc together

PenkeI guess you are interested in Revolution Medicines Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Revolution Medicines Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Revolution Medicines Inc

I send you an email if I find something interesting about Revolution Medicines Inc.

Quick analysis of Revolution Medicines Inc (30 sec.)










What can you expect buying and holding a share of Revolution Medicines Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$11.09
Expected worth in 1 year
$18.02
How sure are you?
42.9%

+ What do you gain per year?

Total Gains per Share
$6.93
Return On Investment
21.5%

For what price can you sell your share?

Current Price per Share
$32.23
Expected price per share
$25.93 - $35.60
How sure are you?
50%

1. Valuation of Revolution Medicines Inc (5 min.)




Live pricePrice per Share (EOD)

$32.23

Intrinsic Value Per Share

$-38.72 - $-45.99

Total Value Per Share

$-27.63 - $-34.90

2. Growth of Revolution Medicines Inc (5 min.)




Is Revolution Medicines Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$1.8b$604.1m$532.5m46.9%

How much money is Revolution Medicines Inc making?

Current yearPrevious yearGrowGrow %
Making money-$106.6m-$61.8m-$44.8m-42.0%
Net Profit Margin-6,293.8%-993.1%--

How much money comes from the company's main activities?

3. Financial Health of Revolution Medicines Inc (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#36 / 1031

Most Revenue
#405 / 1031

Most Profit
#993 / 1031

Most Efficient
#933 / 1031

What can you expect buying and holding a share of Revolution Medicines Inc? (5 min.)

Welcome investor! Revolution Medicines Inc's management wants to use your money to grow the business. In return you get a share of Revolution Medicines Inc.

What can you expect buying and holding a share of Revolution Medicines Inc?

First you should know what it really means to hold a share of Revolution Medicines Inc. And how you can make/lose money.

Speculation

The Price per Share of Revolution Medicines Inc is $32.23. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Revolution Medicines Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Revolution Medicines Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $11.09. Based on the TTM, the Book Value Change Per Share is $1.73 per quarter. Based on the YOY, the Book Value Change Per Share is $0.13 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Revolution Medicines Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.98-3.0%-0.66-2.1%-0.38-1.2%-0.32-1.0%-0.31-1.0%
Usd Book Value Change Per Share6.0018.6%1.735.4%0.130.4%0.531.6%0.531.6%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share6.0018.6%1.735.4%0.130.4%0.531.6%0.531.6%
Usd Price Per Share28.68-26.19-22.14-22.57-21.50-
Price to Earnings Ratio-7.31--10.53--14.94--20.64--19.66-
Price-to-Total Gains Ratio4.78--59.18-228.90--0.73--0.73-
Price to Book Ratio2.59-4.13-6.14-6.10-5.81-
Price-to-Total Gains Ratio4.78--59.18-228.90--0.73--0.73-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share32.23
Number of shares31
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share1.730.53
Usd Total Gains Per Share1.730.53
Gains per Quarter (31 shares)53.6916.28
Gains per Year (31 shares)214.7765.11
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1021520506555
204304200130120
306446350195185
408598500260250
50107410650326315
60128912800391380
70150314950456445
80171817100521510
90193319250586575
100214821400651640

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%0.021.00.00.0%0.021.00.00.0%
Book Value Change Per Share2.02.00.050.0%5.07.00.041.7%8.010.02.040.0%9.010.02.042.9%9.010.02.042.9%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.021.00.0%0.00.021.00.0%
Total Gains per Share2.02.00.050.0%5.07.00.041.7%8.010.02.040.0%9.010.02.042.9%9.010.02.042.9%

Fundamentals of Revolution Medicines Inc

About Revolution Medicines Inc

Revolution Medicines, Inc., a clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers. The company's research and development pipeline comprises RAS(ON) inhibitors designed to be used as monotherapy in combination with other RAS(ON) inhibitors and/or in combination with RAS companion inhibitors or other therapeutic agents, and RAS companion inhibitors for combination treatment strategies. Its RAS(ON) inhibitors include RMC-6236 (multi), RMC-6291 (G12C), and RMC-9805 (G12D), which are in phase 1 clinical trial; and development candidates comprise RMC-5127 (G12V), RMC-0708 (Q61H), and RMC-8839 (G13C), as well as programs focused on G12R and other targets. The company's RAS companion inhibitors include RMC-4630 that is in phase 2 clinical trial; and RMC-5552, which is in phase 1 clinical trial. Revolution Medicines, Inc. was incorporated in 2014 and is headquartered in Redwood City, California.

Fundamental data was last updated by Penke on 2024-03-22 03:04:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Revolution Medicines Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Revolution Medicines Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Revolution Medicines Inc to the Biotechnology industry mean.
  • A Net Profit Margin of -21,770.5% means that $-217.70 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Revolution Medicines Inc:

  • The MRQ is -21,770.5%. The company is making a huge loss. -2
  • The TTM is -6,293.8%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-21,770.5%TTM-6,293.8%-15,476.7%
TTM-6,293.8%YOY-993.1%-5,300.7%
TTM-6,293.8%5Y-1,840.9%-4,452.9%
5Y-1,840.9%10Y-1,758.5%-82.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-21,770.5%-159.2%-21,611.3%
TTM-6,293.8%-202.3%-6,091.5%
YOY-993.1%-263.0%-730.1%
5Y-1,840.9%-452.4%-1,388.5%
10Y-1,758.5%-589.0%-1,169.5%
1.1.2. Return on Assets

Shows how efficient Revolution Medicines Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Revolution Medicines Inc to the Biotechnology industry mean.
  • -7.7% Return on Assets means that Revolution Medicines Inc generated $-0.08 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Revolution Medicines Inc:

  • The MRQ is -7.7%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -8.3%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-7.7%TTM-8.3%+0.6%
TTM-8.3%YOY-8.4%+0.1%
TTM-8.3%5Y-6.8%-1.5%
5Y-6.8%10Y-6.8%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-7.7%-12.5%+4.8%
TTM-8.3%-12.2%+3.9%
YOY-8.4%-11.2%+2.8%
5Y-6.8%-13.3%+6.5%
10Y-6.8%-14.6%+7.8%
1.1.3. Return on Equity

Shows how efficient Revolution Medicines Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Revolution Medicines Inc to the Biotechnology industry mean.
  • -8.8% Return on Equity means Revolution Medicines Inc generated $-0.09 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Revolution Medicines Inc:

  • The MRQ is -8.8%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -9.6%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-8.8%TTM-9.6%+0.8%
TTM-9.6%YOY-10.4%+0.8%
TTM-9.6%5Y-8.6%-1.0%
5Y-8.6%10Y-8.8%+0.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-8.8%-16.0%+7.2%
TTM-9.6%-15.8%+6.2%
YOY-10.4%-13.9%+3.5%
5Y-8.6%-18.2%+9.6%
10Y-8.8%-19.1%+10.3%

1.2. Operating Efficiency of Revolution Medicines Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Revolution Medicines Inc is operating .

  • Measures how much profit Revolution Medicines Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Revolution Medicines Inc to the Biotechnology industry mean.
  • An Operating Margin of -24,256.5% means the company generated $-242.56  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Revolution Medicines Inc:

  • The MRQ is -24,256.5%. The company is operating very inefficient. -2
  • The TTM is -7,063.9%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-24,256.5%TTM-7,063.9%-17,192.6%
TTM-7,063.9%YOY-1,032.2%-6,031.7%
TTM-7,063.9%5Y-2,006.6%-5,057.3%
5Y-2,006.6%10Y-1,916.3%-90.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-24,256.5%-299.5%-23,957.0%
TTM-7,063.9%-208.5%-6,855.4%
YOY-1,032.2%-280.2%-752.0%
5Y-2,006.6%-459.9%-1,546.7%
10Y-1,916.3%-596.9%-1,319.4%
1.2.2. Operating Ratio

Measures how efficient Revolution Medicines Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 243.56 means that the operating costs are $243.56 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Revolution Medicines Inc:

  • The MRQ is 243.565. The company is inefficient in keeping operating costs low. -1
  • The TTM is 71.389. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ243.565TTM71.389+172.176
TTM71.389YOY11.546+59.843
TTM71.3895Y21.074+50.315
5Y21.07410Y20.171+0.902
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ243.5652.817+240.748
TTM71.3893.181+68.208
YOY11.5463.609+7.937
5Y21.0745.554+15.520
10Y20.1717.396+12.775

1.3. Liquidity of Revolution Medicines Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Revolution Medicines Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 13.06 means the company has $13.06 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Revolution Medicines Inc:

  • The MRQ is 13.064. The company is very able to pay all its short-term debts. +2
  • The TTM is 12.851. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ13.064TTM12.851+0.213
TTM12.851YOY9.192+3.659
TTM12.8515Y10.277+2.574
5Y10.27710Y9.921+0.356
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ13.0643.987+9.077
TTM12.8514.440+8.411
YOY9.1925.569+3.623
5Y10.2776.158+4.119
10Y9.9216.492+3.429
1.3.2. Quick Ratio

Measures if Revolution Medicines Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Revolution Medicines Inc to the Biotechnology industry mean.
  • A Quick Ratio of 20.93 means the company can pay off $20.93 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Revolution Medicines Inc:

  • The MRQ is 20.931. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 19.945. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ20.931TTM19.945+0.987
TTM19.945YOY15.796+4.149
TTM19.9455Y17.180+2.764
5Y17.18010Y16.482+0.698
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ20.9313.653+17.278
TTM19.9454.158+15.787
YOY15.7965.515+10.281
5Y17.1806.012+11.168
10Y16.4826.206+10.276

1.4. Solvency of Revolution Medicines Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Revolution Medicines Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Revolution Medicines Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.13 means that Revolution Medicines Inc assets are financed with 12.6% credit (debt) and the remaining percentage (100% - 12.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Revolution Medicines Inc:

  • The MRQ is 0.126. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.130. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.126TTM0.130-0.005
TTM0.130YOY0.184-0.054
TTM0.1305Y0.197-0.067
5Y0.19710Y0.208-0.011
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1260.336-0.210
TTM0.1300.330-0.200
YOY0.1840.267-0.083
5Y0.1970.367-0.170
10Y0.2080.378-0.170
1.4.2. Debt to Equity Ratio

Measures if Revolution Medicines Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Revolution Medicines Inc to the Biotechnology industry mean.
  • A Debt to Equity ratio of 14.4% means that company has $0.14 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Revolution Medicines Inc:

  • The MRQ is 0.144. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.150. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.144TTM0.150-0.006
TTM0.150YOY0.226-0.076
TTM0.1505Y0.267-0.117
5Y0.26710Y0.291-0.024
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1440.376-0.232
TTM0.1500.398-0.248
YOY0.2260.334-0.108
5Y0.2670.431-0.164
10Y0.2910.476-0.185

2. Market Valuation of Revolution Medicines Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Revolution Medicines Inc generates.

  • Above 15 is considered overpriced but always compare Revolution Medicines Inc to the Biotechnology industry mean.
  • A PE ratio of -7.31 means the investor is paying $-7.31 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Revolution Medicines Inc:

  • The EOD is -8.215. Based on the earnings, the company is expensive. -2
  • The MRQ is -7.310. Based on the earnings, the company is expensive. -2
  • The TTM is -10.530. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-8.215MRQ-7.310-0.905
MRQ-7.310TTM-10.530+3.220
TTM-10.530YOY-14.939+4.409
TTM-10.5305Y-20.640+10.110
5Y-20.64010Y-19.657-0.983
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-8.215-2.697-5.518
MRQ-7.310-2.422-4.888
TTM-10.530-2.709-7.821
YOY-14.939-4.116-10.823
5Y-20.640-6.257-14.383
10Y-19.657-6.478-13.179
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Revolution Medicines Inc:

  • The EOD is -10.799. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -9.610. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -12.678. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-10.799MRQ-9.610-1.189
MRQ-9.610TTM-12.678+3.068
TTM-12.678YOY-15.512+2.834
TTM-12.6785Y-23.055+10.377
5Y-23.05510Y-21.957-1.098
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-10.799-3.344-7.455
MRQ-9.610-2.939-6.671
TTM-12.678-3.486-9.192
YOY-15.512-5.592-9.920
5Y-23.055-8.464-14.591
10Y-21.957-8.872-13.085
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Revolution Medicines Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 2.59 means the investor is paying $2.59 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Revolution Medicines Inc:

  • The EOD is 2.907. Based on the equity, the company is underpriced. +1
  • The MRQ is 2.586. Based on the equity, the company is underpriced. +1
  • The TTM is 4.127. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD2.907MRQ2.586+0.320
MRQ2.586TTM4.127-1.541
TTM4.127YOY6.138-2.010
TTM4.1275Y6.100-1.973
5Y6.10010Y5.809+0.290
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD2.9072.198+0.709
MRQ2.5862.042+0.544
TTM4.1272.121+2.006
YOY6.1382.907+3.231
5Y6.1003.682+2.418
10Y5.8094.114+1.695
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Revolution Medicines Inc.

3.1. Institutions holding Revolution Medicines Inc

Institutions are holding 95.937% of the shares of Revolution Medicines Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Wellington Management Company LLP9.08570.079714882086430961140.7626
2023-09-30Vanguard Group Inc5.88750.006696435913030883.2449
2023-09-30BlackRock Inc5.41610.007188714146137987.4331
2023-12-31Farallon Capital Management, L.L.C.4.11290.959167368543411374102.5829
2023-12-31Casdin Capital, LLC3.488916.08855714775-490702-7.9076
2023-09-30EcoR1 Capital, LLC3.40545.20785577863-1620837-22.5157
2023-12-31Bellevue Group AG3.10812.233450910003695007.8259
2023-09-30Nextech Invest AG2.954640.5903483952900
2023-09-30Boxer Capital LLC2.85986.9023468426400
2023-12-31T. Rowe Price Associates, Inc.2.83060.01794636353-470394-9.2112
2023-09-30JPMorgan Chase & Co2.61290.013142799193121667.8676
2023-09-30Bvf Inc2.43062.97163981212-2274376-36.3575
2023-09-30State Street Corporation2.36120.00593867610-876639-18.4779
2023-12-31ARCH VENTURE CORP1.974156.7173233490-807004-19.9729
2023-12-31Woodline Partners LP1.80710.92322960040-185405-5.8944
2023-09-30Baker Bros Advisors LP1.64320.4294269149300
2023-12-31HHG PLC1.34280.03762199480-49354-2.1946
2023-09-30Holocene Advisors, LP1.33750.26552190722126620.5813
2023-09-30Geode Capital Management, LLC1.26540.006820727321242726.378
2023-12-31Dimensional Fund Advisors, Inc.1.09610.0151795421-48619-2.6365
Total 61.0205133.477899949848+2633141+2.6%

3.2. Funds holding Revolution Medicines Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Vanguard Health Care Inv3.91610.39856449517174671537.142
2024-01-31Vanguard Total Stock Mkt Idx Inv3.01370.0093496329282910.1673
2023-09-30BB Biotech AG Ord2.82155.2614646700-28300-0.6053
2024-01-31Vanguard Small Cap Index2.41260.08353973270109680.2768
2024-02-29iShares Russell 2000 ETF2.11350.16453480666-569-0.0163
2024-02-29SPDR® S&P Biotech ETF2.08371.27753431684641401.9047
2024-01-31Vanguard Small Cap Growth Index Inv1.34650.19272217474104070.4715
2023-12-31US Small-Cap Growth II Equity Comp1.2170.197200421126991715.5635
2024-01-31Vanguard Institutional Extnd Mkt Idx Tr1.15880.055119084606730.0353
2023-12-31T. Rowe Price New Horizons1.03320.19721701538-32756-1.8887
2023-12-31Vanguard Explorer Inv0.98530.2177162274633313025.8317
2023-12-31Fidelity Small Cap Index0.86850.16141430275861516.4095
2023-12-31T. Rowe Price Health Sciences0.86090.27641417789-136145-8.7613
2024-01-31JPMorgan Small Cap Growth A0.80231.01691321364-38629-2.8404
2024-01-31Fidelity Growth Compy Commingled Pl O0.78020.04971284844686095.6411
2024-01-31JPM Global Healthcare C (acc) USD0.75060.7445123610600
2024-02-29iShares Biotechnology ETF0.65180.41611073524-4830-0.4479
2024-02-29iShares Russell 2000 Growth ETF0.56870.243293662526810.2871
2024-01-31Fidelity Growth Company Fund0.56470.0471930047272063.0134
2024-01-31State St Russell Sm/Mid Cp® Indx NL Cl C0.51510.0615848324110001.3137
Total 28.464711.070846878456+2398659+5.1%

3.3. Insider Transactions

Insiders are holding 2.452% of the shares of Revolution Medicines Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-03-18Jeff CisliniSELL125231.58
2024-03-18Margaret A HornSELL291431.58
2024-03-18Stephen Michael KelseySELL212331.58
2024-03-18Jack AndersSELL126131.58
2024-01-22Jeff CisliniSELL150027
2024-01-08Stephen Michael KelseySELL333729.01
2023-12-27Stephen Michael KelseySELL3333429.01
2023-12-18Jack AndersSELL177525.9
2023-12-18Jeff CisliniSELL122925.9
2023-12-18Margaret A HornSELL299325.9
2023-12-18Mark A GoldsmithSELL816525.9
2023-12-15Margaret A HornSELL500026.64
2023-11-20Jeff CisliniSELL150021.7
2023-10-16Margaret A HornSELL2500033.95
2023-10-11Stephen Michael KelseySELL1666729.05
2023-09-28Jeff CisliniSELL200028.2
2023-09-18Jack AndersSELL142731.31
2023-09-18Jeff CisliniSELL121431.31
2023-09-18Margaret A HornSELL251431.31
2023-09-18Stephen Michael KelseySELL206031.31

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Revolution Medicines Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--6.0041.732+247%0.125+4687%0.525+1043%0.528+1037%
Book Value Per Share--11.0896.902+61%3.668+202%3.597+208%3.454+221%
Current Ratio--13.06412.851+2%9.192+42%10.277+27%9.921+32%
Debt To Asset Ratio--0.1260.130-3%0.184-32%0.197-36%0.208-40%
Debt To Equity Ratio--0.1440.150-4%0.226-36%0.267-46%0.291-51%
Dividend Per Share----0%-0%-0%-0%
Eps---0.981-0.662-32%-0.378-62%-0.325-67%-0.314-68%
Free Cash Flow Per Share---0.746-0.544-27%-0.357-52%-0.274-63%-0.264-65%
Free Cash Flow To Equity Per Share--4.3501.322+229%0.101+4228%0.438+892%0.415+948%
Gross Profit Margin--1.0081.002+1%1.000+1%1.000+1%1.000+1%
Intrinsic Value_10Y_max---45.986--------
Intrinsic Value_10Y_min---38.717--------
Intrinsic Value_1Y_max---1.963--------
Intrinsic Value_1Y_min---1.927--------
Intrinsic Value_3Y_max---7.914--------
Intrinsic Value_3Y_min---7.515--------
Intrinsic Value_5Y_max---16.296--------
Intrinsic Value_5Y_min---14.952--------
Market Cap5307958700.000+11%4723309200.0004313642825.000+9%3645413150.000+30%3717712060.000+27%3540678152.381+33%
Net Profit Margin---217.705-62.938-71%-9.931-95%-18.409-92%-17.585-92%
Operating Margin---242.565-70.639-71%-10.322-96%-20.066-92%-19.163-92%
Operating Ratio--243.56571.389+241%11.546+2010%21.074+1056%20.171+1107%
Pb Ratio2.907+11%2.5864.127-37%6.138-58%6.100-58%5.809-55%
Pe Ratio-8.215-12%-7.310-10.530+44%-14.939+104%-20.640+182%-19.657+169%
Price Per Share32.230+11%28.68026.193+9%22.135+30%22.574+27%21.499+33%
Price To Free Cash Flow Ratio-10.799-12%-9.610-12.678+32%-15.512+61%-23.055+140%-21.957+128%
Price To Total Gains Ratio5.368+11%4.777-59.177+1339%228.905-98%-0.733+115%-0.733+115%
Quick Ratio--20.93119.945+5%15.796+33%17.180+22%16.482+27%
Return On Assets---0.077-0.083+8%-0.084+9%-0.068-12%-0.068-12%
Return On Equity---0.088-0.096+9%-0.104+17%-0.086-3%-0.088-1%
Total Gains Per Share--6.0041.732+247%0.125+4687%0.525+1043%0.528+1037%
Usd Book Value--1826194000.0001136676250.000+61%604110250.000+202%592429250.000+208%568821142.857+221%
Usd Book Value Change Per Share--6.0041.732+247%0.125+4687%0.525+1043%0.528+1037%
Usd Book Value Per Share--11.0896.902+61%3.668+202%3.597+208%3.454+221%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.981-0.662-32%-0.378-62%-0.325-67%-0.314-68%
Usd Free Cash Flow---122880000.000-89575250.000-27%-58804250.000-52%-45121400.000-63%-43543809.524-65%
Usd Free Cash Flow Per Share---0.746-0.544-27%-0.357-52%-0.274-63%-0.264-65%
Usd Free Cash Flow To Equity Per Share--4.3501.322+229%0.101+4228%0.438+892%0.415+948%
Usd Market Cap5307958700.000+11%4723309200.0004313642825.000+9%3645413150.000+30%3717712060.000+27%3540678152.381+33%
Usd Price Per Share32.230+11%28.68026.193+9%22.135+30%22.574+27%21.499+33%
Usd Profit---161537000.000-106693750.000-34%-61884000.000-62%-50861250.000-69%-48979238.095-70%
Usd Revenue--742000.0002895000.000-74%8845000.000-92%8468700.000-91%8558142.857-91%
Usd Total Gains Per Share--6.0041.732+247%0.125+4687%0.525+1043%0.528+1037%
 EOD+6 -2MRQTTM+21 -13YOY+20 -145Y+19 -1510Y+19 -15

4.2. Fundamental Score

Let's check the fundamental score of Revolution Medicines Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-8.215
Price to Book Ratio (EOD)Between0-12.907
Net Profit Margin (MRQ)Greater than0-217.705
Operating Margin (MRQ)Greater than0-242.565
Quick Ratio (MRQ)Greater than120.931
Current Ratio (MRQ)Greater than113.064
Debt to Asset Ratio (MRQ)Less than10.126
Debt to Equity Ratio (MRQ)Less than10.144
Return on Equity (MRQ)Greater than0.15-0.088
Return on Assets (MRQ)Greater than0.05-0.077
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of Revolution Medicines Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5057.429
Ma 20Greater thanMa 5031.395
Ma 50Greater thanMa 10029.957
Ma 100Greater thanMa 20027.346
OpenGreater thanClose31.580
Total3/5 (60.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Accumulated Other Comprehensive Income  -1,7801,224-556-695-1,251380-8711,415544



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets2,088,591
Total Liabilities262,397
Total Stockholder Equity1,826,194
 As reported
Total Liabilities 262,397
Total Stockholder Equity+ 1,826,194
Total Assets = 2,088,591

Assets

Total Assets2,088,591
Total Current Assets1,879,281
Long-term Assets209,310
Total Current Assets
Cash And Cash Equivalents 696,148
Short-term Investments 1,156,807
Net Receivables 1,254
Other Current Assets 25,072
Total Current Assets  (as reported)1,879,281
Total Current Assets  (calculated)1,879,281
+/-0
Long-term Assets
Property Plant Equipment 100,014
Goodwill 14,608
Intangible Assets 57,739
Long-term Assets Other 7,032
Long-term Assets  (as reported)209,310
Long-term Assets  (calculated)179,393
+/- 29,917

Liabilities & Shareholders' Equity

Total Current Liabilities143,851
Long-term Liabilities118,546
Total Stockholder Equity1,826,194
Total Current Liabilities
Short-term Debt 7,369
Accounts payable 61,788
Other Current Liabilities 74,694
Total Current Liabilities  (as reported)143,851
Total Current Liabilities  (calculated)143,851
+/-0
Long-term Liabilities
Capital Lease Obligations 87,944
Long-term Liabilities Other 1,458
Long-term Liabilities  (as reported)118,546
Long-term Liabilities  (calculated)89,402
+/- 29,144
Total Stockholder Equity
Common Stock16
Retained Earnings -1,137,708
Accumulated Other Comprehensive Income 544
Other Stockholders Equity 2,963,342
Total Stockholder Equity (as reported)1,826,194
Total Stockholder Equity (calculated)1,826,194
+/-0
Other
Capital Stock16
Cash and Short Term Investments 1,852,955
Common Stock Shares Outstanding 141,184
Liabilities and Stockholders Equity 2,088,591
Net Debt -608,204
Net Invested Capital 1,826,194
Net Working Capital 1,735,430
Property Plant and Equipment Gross 117,708
Short Long Term Debt Total 87,944



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-31
> Total Assets 
170,586
0
0
234,745
220,529
454,341
453,957
595,070
567,401
811,651
774,046
734,976
737,988
682,774
632,802
825,910
811,930
1,073,248
1,073,709
984,232
2,088,591
2,088,591984,2321,073,7091,073,248811,930825,910632,802682,774737,988734,976774,046811,651567,401595,070453,957454,341220,529234,74500170,586
   > Total Current Assets 
85,431
0
0
149,117
133,981
362,086
340,381
482,898
454,122
697,405
661,011
623,536
577,054
534,343
483,046
675,108
660,185
922,753
922,092
824,467
1,879,281
1,879,281824,467922,092922,753660,185675,108483,046534,343577,054623,536661,011697,405454,122482,898340,381362,086133,981149,1170085,431
       Cash And Cash Equivalents 
69,586
0
0
21,824
16,659
182,669
23,976
64,871
104,268
351,595
195,600
129,154
108,497
97,667
105,781
178,941
161,412
427,222
380,330
358,399
696,148
696,148358,399380,330427,222161,412178,941105,78197,667108,497129,154195,600351,595104,26864,87123,976182,66916,65921,8240069,586
       Short-term Investments 
0
0
0
114,464
106,099
165,279
301,469
401,269
336,473
329,998
450,722
479,501
468,557
421,087
355,652
476,072
483,531
482,578
529,159
454,796
1,156,807
1,156,807454,796529,159482,578483,531476,072355,652421,087468,557479,501450,722329,998336,473401,269301,469165,279106,099114,464000
       Net Receivables 
7,303
0
0
8,950
8,737
8,450
7,331
9,299
6,393
7,564
6,527
7,412
5,929
5,383
5,624
4,940
4,673
3,995
2,510
309
1,254
1,2543092,5103,9954,6734,9405,6245,3835,9297,4126,5277,5646,3939,2997,3318,4508,7378,950007,303
       Inventory 
6,597
0
0
0
0
0
0
0
0
0
0
0
-12,719
0
0
0
0
0
0
0
0
00000000-12,719000000000006,597
       Other Current Assets 
1,945
0
0
3,879
2,486
5,688
7,605
7,459
6,988
8,248
8,162
7,469
6,790
10,206
15,989
15,155
10,569
8,958
10,093
10,963
25,072
25,07210,96310,0938,95810,56915,15515,98910,2066,7907,4698,1628,2486,9887,4597,6055,6882,4863,879001,945
   > Long-term Assets 
85,155
0
0
85,628
86,548
92,255
113,576
112,172
113,279
114,246
113,035
111,440
160,934
148,431
149,756
150,802
151,745
150,495
151,617
159,765
209,310
209,310159,765151,617150,495151,745150,802149,756148,431160,934111,440113,035114,246113,279112,172113,57692,25586,54885,6280085,155
       Property Plant Equipment 
6,872
0
0
6,780
7,147
15,243
35,994
35,229
36,337
37,574
36,669
35,341
71,236
71,626
73,344
74,526
73,736
72,838
73,451
73,408
100,014
100,01473,40873,45172,83873,73674,52673,34471,62671,23635,34136,66937,57436,33735,22935,99415,2437,1476,780006,872
       Goodwill 
14,608
0
0
14,608
14,608
14,608
14,608
14,608
14,608
14,608
14,608
14,608
14,608
14,608
14,608
14,608
14,608
14,608
14,608
14,608
14,608
14,60814,60814,60814,60814,60814,60814,60814,60814,60814,60814,60814,60814,60814,60814,60814,60814,60814,6080014,608
       Intangible Assets 
63,082
0
0
62,280
62,013
61,746
61,479
61,212
60,945
60,678
60,410
60,143
59,876
59,609
59,342
59,075
58,807
58,540
58,273
58,006
57,739
57,73958,00658,27358,54058,80759,07559,34259,60959,87660,14360,41060,67860,94561,21261,47961,74662,01362,2800063,082
       Other Assets 
593
0
0
1,960
2,780
658
1,495
1,123
1,389
1,386
1,348
1,348
2,495
2,588
2,462
2,593
4,594
4,509
5,285
0
0
005,2854,5094,5942,5932,4622,5882,4951,3481,3481,3861,3891,1231,4956582,7801,96000593
> Total Liabilities 
73,927
0
0
69,077
67,994
69,025
93,459
90,000
92,725
89,071
89,040
96,772
135,420
131,781
133,961
144,491
126,742
121,030
142,874
146,774
262,397
262,397146,774142,874121,030126,742144,491133,961131,781135,42096,77289,04089,07192,72590,00093,45969,02567,99469,0770073,927
   > Total Current Liabilities 
30,552
0
0
38,640
43,052
41,514
43,737
42,384
47,176
43,759
45,801
51,891
18,931
57,458
63,539
73,271
61,984
54,635
78,059
85,541
143,851
143,85185,54178,05954,63561,98473,27163,53957,45818,93151,89145,80143,75947,17642,38443,73741,51443,05238,6400030,552
       Short-term Debt 
147
0
0
157
172
3,435
3,726
3,709
3,672
3,700
4,926
4,959
6,214
6,331
6,030
7,017
6,773
5,921
5,718
5,755
7,369
7,3695,7555,7185,9216,7737,0176,0306,3316,2144,9594,9263,7003,6723,7093,7263,43517215700147
       Accounts payable 
5,236
0
0
6,013
11,400
7,877
10,173
6,656
12,609
9,650
10,435
10,491
14,057
14,174
14,067
24,382
21,306
19,912
29,784
29,627
61,788
61,78829,62729,78419,91221,30624,38214,06714,17414,05710,49110,4359,65012,6096,65610,1737,87711,4006,013005,236
       Other Current Liabilities 
8,339
0
0
12,961
14,356
13,800
15,256
18,910
10,303
20,445
22,103
23,776
-20,271
25,520
33,756
32,186
29,446
27,368
350
480
74,694
74,69448035027,36829,44632,18633,75625,520-20,27123,77622,10320,44510,30318,91015,25613,80014,35612,961008,339
   > Long-term Liabilities 
43,375
0
0
30,437
24,942
27,511
49,722
47,616
45,549
45,312
43,239
44,881
116,489
74,323
70,422
71,220
64,758
66,395
64,815
61,233
118,546
118,54661,23364,81566,39564,75871,22070,42274,323116,48944,88143,23945,31245,54947,61649,72227,51124,94230,4370043,375
       Other Liabilities 
43,375
0
0
0
24,942
20,108
19,385
17,947
16,557
17,018
15,673
18,054
14,651
14,740
11,500
13,037
7,326
8,719
7,277
0
0
007,2778,7197,32613,03711,50014,74014,65118,05415,67317,01816,55717,94719,38520,10824,94200043,375
       Deferred Long Term Liability 
0
0
0
0
2,100
0
0
0
7,444
7,444
7,444
7,444
500
7,444
7,444
7,148
600
7,025
0
0
0
0007,0256007,1487,4447,4445007,4447,4447,4447,4440002,1000000
> Total Stockholder Equity
96,659
0
0
165,668
152,535
385,316
360,498
505,070
474,676
722,580
685,006
638,204
602,568
550,993
498,841
681,419
685,188
952,218
930,835
837,458
1,826,194
1,826,194837,458930,835952,218685,188681,419498,841550,993602,568638,204685,006722,580474,676505,070360,498385,316152,535165,6680096,659
   Common Stock
3
0
0
4
-5,633
6
6
7
7
8
8
8
8
8
8
9
9
11
11
11
16
16111111998888887766-5,6334003
   Retained Earnings -1,137,708-976,171-867,737-769,439-701,341-644,834-571,505-510,283-452,636-399,960-347,020-302,721-265,545-231,341-204,120-176,905-157,386-142,79000-109,722
   Accumulated Other Comprehensive Income 
-3,623
0
0
54
74
36
291
211
116
63
9
-40
-376
-1,284
-1,765
-2,419
-1,780
-556
-1,251
-871
544
544-871-1,251-556-1,780-2,419-1,765-1,284-376-4096311621129136745400-3,623
   Capital Surplus 
0
0
0
3,290
4,738
562,179
0
0
740,098
1,025,230
1,032,009
1,038,196
1,055,572
1,062,552
1,072,103
1,328,663
0
1,722,202
0
0
0
0001,722,20201,328,6631,072,1031,062,5521,055,5721,038,1961,032,0091,025,230740,09800562,1794,7383,290000
   Treasury Stock000000000000000000000
   Other Stockholders Equity 
210,001
0
0
313,681
10,371
107,838
110,364
141,123
740,098
213,579
257,963
303,220
1,055,572
1,062,552
1,072,103
1,328,663
1,388,300
1,722,202
1,799,812
1,814,489
2,963,342
2,963,3421,814,4891,799,8121,722,2021,388,3001,328,6631,072,1031,062,5521,055,572303,220257,963213,579740,098141,123110,364107,83810,371313,68100210,001



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue11,580
Cost of Revenue-9,309
Gross Profit2,2712,271
 
Operating Income (+$)
Gross Profit2,271
Operating Expense-489,456
Operating Income-487,185-487,185
 
Operating Expense (+$)
Research Development417,034
Selling General Administrative75,621
Selling And Marketing Expenses3,199
Operating Expense489,456495,854
 
Net Interest Income (+$)
Interest Income47,482
Interest Expense-303
Other Finance Cost-0
Net Interest Income47,179
 
Pretax Income (+$)
Operating Income-487,185
Net Interest Income47,179
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-439,891-534,479
EBIT - interestExpense = -487,488
-439,891
-436,064
Interest Expense303
Earnings Before Interest and Taxes (EBIT)-487,185-439,588
Earnings Before Interest and Taxes (EBITDA)-477,876
 
After tax Income (+$)
Income Before Tax-439,891
Tax Provision--3,524
Net Income From Continuing Ops-436,367-436,367
Net Income-436,367
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses498,765
Total Other Income/Expenses Net47,294-47,179
 

Technical Analysis of Revolution Medicines Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Revolution Medicines Inc. The general trend of Revolution Medicines Inc is BULLISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Revolution Medicines Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (85.7%) Bearish trend (-85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Revolution Medicines Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 34.59 < 35.50 < 35.60.

The bearish price targets are: 29.00 > 28.43 > 25.93.

Tweet this
Revolution Medicines Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Revolution Medicines Inc. The current mas is .

The long score for the Moving Averages is 13/14.
The longshort score for the Moving Averages is 12/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Revolution Medicines Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Revolution Medicines Inc. The current macd is 0.3848904.

The long score for the Moving Average Convergence/Divergence (MACD) is 2/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 0/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Revolution Medicines Inc price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Revolution Medicines Inc. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Revolution Medicines Inc price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Revolution Medicines Inc Daily Moving Average Convergence/Divergence (MACD) ChartRevolution Medicines Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Revolution Medicines Inc. The current adx is 22.11.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Revolution Medicines Inc shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
Revolution Medicines Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Revolution Medicines Inc. The current sar is 33.17.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Revolution Medicines Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Revolution Medicines Inc. The current rsi is 57.43. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending up: The RSI is trending up. +1
Revolution Medicines Inc Daily Relative Strength Index (RSI) ChartRevolution Medicines Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Revolution Medicines Inc. The current phase is Continuation in bull market.

The long score for the Stochastic Oscillator is 4/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Revolution Medicines Inc price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Revolution Medicines Inc Daily Stochastic Oscillator ChartRevolution Medicines Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Revolution Medicines Inc. The current cci is 44.01.

Revolution Medicines Inc Daily Commodity Channel Index (CCI) ChartRevolution Medicines Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Revolution Medicines Inc. The current cmo is 16.68.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Revolution Medicines Inc Daily Chande Momentum Oscillator (CMO) ChartRevolution Medicines Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Revolution Medicines Inc. The current willr is -48.9626556.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Revolution Medicines Inc is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Revolution Medicines Inc Daily Williams %R ChartRevolution Medicines Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Revolution Medicines Inc.

Revolution Medicines Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Revolution Medicines Inc. The current atr is 1.34446671.

Revolution Medicines Inc Daily Average True Range (ATR) ChartRevolution Medicines Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Revolution Medicines Inc. The current obv is 4,731,381.

Revolution Medicines Inc Daily On-Balance Volume (OBV) ChartRevolution Medicines Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Revolution Medicines Inc. The current mfi is 42.13.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Revolution Medicines Inc Daily Money Flow Index (MFI) ChartRevolution Medicines Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Revolution Medicines Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-07MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2023-11-10STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-14STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-15DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2023-11-20CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-21DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-22STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-24DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2023-11-28WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-29CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-11-30BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-04STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-05MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-07STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-11STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-12STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-13SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-14STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-20MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-22STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-26BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-28STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-29RSI SHORT ENTRY LONG CLOSE70 crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-08WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-09MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-11SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-16CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-17DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-22CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-23DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-24CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-25SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-29STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-31STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-01DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-02WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-05MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-06STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-13SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-14CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-20CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-21DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-02-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-02-23STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-27STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-29CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-04SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-05STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-07MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-03-08SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-03-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-12STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-13STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-14RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-03-18CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-21CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-22STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-25WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).

6.3. Candlestick Patterns

Revolution Medicines Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Revolution Medicines Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5057.429
Ma 20Greater thanMa 5031.395
Ma 50Greater thanMa 10029.957
Ma 100Greater thanMa 20027.346
OpenGreater thanClose31.580
Total3/5 (60.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Revolution Medicines Inc with someone you think should read this too:
  • Are you bullish or bearish on Revolution Medicines Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Revolution Medicines Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Revolution Medicines Inc

I send you an email if I find something interesting about Revolution Medicines Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Revolution Medicines Inc.

Receive notifications about Revolution Medicines Inc in your mailbox!